Home > Healthcare > Drug Device Combination > Therapeutic Systems > Facial Palsy Market

Facial Palsy Market Size

  • Report ID: GMI9166
  • Published Date: Apr 2024
  • Report Format: PDF

Facial Palsy Market Size

Facial Palsy Market size was valued at USD 2.7 billion in 2023 and is projected to grow at a CAGR of 4.7% between 2024 and 2032. Increasing prevalence of facial paralysis, rising awareness for early screening and diagnosis, and growing demand for facial reanimation surgeries is driving the growth in market. Additionally, availability of advanced therapeutical treatment options such as electrotherapy is also supporting the revenue growth in market.


Facial palsy, or facial paralysis, is a disorder marked by the absence of voluntary muscle control on one side of the face. High incidence of various facial paralysis conditions, including Bell's palsy and facial nerve injuries caused by trauma, as well as neurological disorders have surged the demand for facial palsy diagnosis and treatments, globally. According to July 2023 study published in National Centers for Biotechnology Information, bell’s palsy has an incidence of 10-40 per 100,000 people globally and it is recurrent in up to 10% of patients. Given the high incidence rate, there is a substantial global demand for both treatment and diagnosis of facial palsy, thus driving facial palsy market growth.


Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of facial palsy reached USD 2.7 billion in 2023 and is set to witness 4.7% CAGR throughout 2032, owing to the increasing prevalence of facial paralysis, rising awareness for early screening and diagnosis.

The bell’s palsy segment accounted for a share of 72.7% in 2023, attributed to high incidence rate of bell’s palsy, increase in awareness for bell’s palsy treatment, and growing research focus for developing advanced therapeutics for the treatment of this condition.

North America market will reach USD 1.5 billion by 2032, due to the significant awareness for early diagnosis of facial palsy and its treatment, availability of advanced healthcare infrastructure in the region.

Brainlab AG (Dr. Langer Medical GmbH), GE Healthcare, GlaxoSmithKline plc, iTENS Australia, Johnson & Johnson Services, Inc., MED-EL Medical Electronics, Medtronic plc, Natus Medical, Nihon Kohden Corporation, Novartis AG, Pfizer Inc., Sanofi, Siemens Healthineers AG, TensCare Ltd, and Teva Pharmaceutical Industries Ltd.

Facial Palsy Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 247
  • Countries covered: 22
  • Pages: 190
 Download Free Sample